Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection.
A series of hydantoin derivatives has been discovered as highly potent nonpeptide antagonists for the human CCR5 receptor. The synthesis, SAR, and biological profiles of this class of antagonists are described.